The advantage of Herceptin SC and advantage of the originator

Abstract

Trastuzumab (Herceptin) is breakthrough molecule in HER2+ breast cancer treatment. The s.c. administration has the same efficacy and safety profile compared to the original i.v. formula.

The s.c. form spares time both of the patients and the nursing staff.

Keywords

• Breast cancer
• trastuzumab